Title
Date
22 July, 2025
CNS Pharmaceuticals to Participate in the Virtual Investor "What's Your Story" Summer Spotlight On-Demand Conference
18 July, 2025
CNS Pharmaceuticals Announces Reverse Stock Split
05 June, 2025
CNS Pharmaceuticals' Chief Medical Officer Sandra Silberman MD PhD to Present at the 2025 Brain Tumor Biotech Summit
16 May, 2025
CNS Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Corporate Update
There are no press releases that match the selected filters.
View More
Stay Updated
Your email alerts were set.
The following alerts could not be set: